Mark J. Pykett
2011
In 2011, Mark J. Pykett earned a total compensation of $745.4K as Chief Executive Officer at Navidea Biopharmaceuticals, a 4% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $175,867 |
|---|---|
| Salary | $363,249 |
| Stock Awards | $201,450 |
| Other | $4,788 |
| Total | $745,354 |
Pykett received $363.2K in salary, accounting for 49% of the total pay in 2011.
Pykett also received $175.9K in non-equity incentive plan, $201.5K in stock awards and $4.8K in other compensation.
Rankings
In 2011, Mark J. Pykett's compensation ranked 6,713th out of 10,747 executives tracked by ExecPay. In other words, Pykett earned more than 37.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,713 out of 10,747 | 38th |
Division Manufacturing | 2,436 out of 3,960 | 39th |
Major group Chemicals And Allied Products | 578 out of 1,033 | 44th |
Industry group Drugs | 383 out of 781 | 51st |
Industry In Vitro and In Vivo Diagnostic Substances | 17 out of 43 | 61st |
Source: SEC filing on June 6, 2014.
Pykett's colleagues
We found five more compensation records of executives who worked with Mark J. Pykett at Navidea Biopharmaceuticals in 2011.
2011
Thomas Tulip
Navidea Biopharmaceuticals
President and Chief Business Officer
2011
David Bupp
Navidea Biopharmaceuticals
Chief Executive Officer
2011
Frederick Cope
Navidea Biopharmaceuticals
Chief Scientific Officer
2011
Brent Larson
Navidea Biopharmaceuticals
Chief Financial Officer
2011
Rodger Brown
Navidea Biopharmaceuticals